Vedolizumab – JoelGalvan

Business

Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016

6 min read

Posted on August 5, 2025

by Joelgalvan

Article content AMSTERDAM, ZUG, Switzerland & GDAŃSK, Poland — Polpharma Biologics S.A. (“Polpharma Biologics”) announces a global (except for Middle…

JoelGalvan

Tag: Vedolizumab

Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016

Recent Posts

Recent Comments

Archives

Categories